Varda Space Industries Raises $251 Million Series D Led By Lux Capital And Natural Capital

Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital, bringing its total funding to $598 million. The El Segundo, Calif.-based space biotech company plans to use the capital to scale in-space pharmaceutical processing, increase launch cadence and advance toward its goal of producing the first medicine manufactured in space, with co-founder and President Delian Asparouhov saying the round will help deepen pharmaceutical partnerships and accelerate that milestone. FOUNDERS: Will Bruey & Delian Asparouhov INVESTORS: Lux Capital, Natural Capital, Founders Fund, Khosla Ventures, Caffeinated Capital, General Catalyst, 8090 Industries, Giant Step & Also Capital ROUND: Series D AMOUNT: $251,000,000 HQ: El Segundo, California #VentureCapital #VardaSpaceIndustries #WillBruey #DelianAsparouhov #TradedVC